Drug Database
Back to search

Belgium· BE-AMP-SAM260881-00

Copaxone 20 mg/ml

A glatiramer acetate product containing glatiramer acetate, registered in Belgium by Teva. The same ATC class is registered in 14 of our 19 countries.

ATC L03AX13

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCopaxone 20 mg/mlATCL03AX13REGISTER NO.BE-AMP-SAM260881-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glatiramer acetateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glatiramer acetate is registered in 14 of 19 countries.

Countries holding a registration under ATC L03AX13 (glatiramer acetate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose
Search glatiramer acetate products by name

Glatiramer acetate · ATC L03AX13

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Glatiramer Acetate
Manufacturer
Teva
Country
Belgium (BE)
ATC code
L03AX13
ATC class
Glatiramer acetate
Defined daily dose
20 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    2173870
    EUR 493.12
  • be_apb
    0778472

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for glatiramer acetate.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glatiramer acetate against other medicinesHow interaction checks work

Glatiramer acetate · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • NatalizumabL04AA23severe
  • NatalizumabL04AG03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glatiramer acetate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glatiramer acetate products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Copaxone, Perscleran
  • Bulgaria · Копаксон, Ремурел
  • Cyprus · Clift, Copaxone
  • Czechia · Copaxone, Remurel
  • Germany · Clift, Copaxone
  • Denmark · Copaxone, Copemyl
  • Estonia · Copaxone, Remurel
  • Spain · Copaxone, Glatiramero Viatris
  • Finland · Copaxone, Glatimyl
  • France · Copaxone, Copaxone Pen
  • United Kingdom (Northern Ireland) · Brabio, Copaxone
  • Greece · Clift, Copaxone
  • Croatia · Copaxone, Remurel
  • Hungary · Copaxone, Remurel
  • Ireland · Brabio, Copaxone
  • Iceland · Copaxone, Remurel
  • Italy · Copaxone, Copemyl
  • Lithuania · Copaxone, Remurel
  • Luxembourg · Copaxone, Copaxone Pen
  • Latvia · Copaxone, Remurel
  • Malta · Galtipex
  • Netherlands · Brabio, Copaxone
  • Norway · Copaxone, Copemyl
  • Poland · Copaxone, Remurel
  • Portugal · Acetato De Glatirâmero Viatris, Clift
  • Romania · Copaxone, Remurel
  • Sweden · Copaxone, Glatimyl
  • Slovenia · Copaxone, Remurel
  • Slovakia · Copaxone, Copaxone Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/06584bca-c32d-4ac2-84af-6d147bd66339
GET /v1/drugs/06584bca-c32d-4ac2-84af-6d147bd66339?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Copaxone 20 mg/ml",
  "name_fr": "Copaxone 20 mg/ml",
  "name_nl": "Copaxone 20 mg/ml",
  "amp_code": "SAM260881-00",
  "strengths": [
    "20.0000",
    "18.0000",
    "40.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Glatiramer Acetate",
    "Glatiramer",
    "Mannitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Glatiramer Acetate",
  "authorisation_numbers": [
    "BE260881"
  ]
}
API referenceMCP serverPlans

See everything about glatiramer acetate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console